Want to join the conversation?
$VSTO expects FY17 EBITDA margins at about 15%. $VSTO's FY17 financial guidance reflects the momentum created by its strong overall performance in FY16 and recent acquisitions, as well as its commitment to investing in future growth. The company expects FY17 R&D spending to be about $30MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?